概述

PREGNA-RISK: Pregnancy Risk Stratification in SLE/APS

Overview

Quantitative risk stratification tool for pregnancy in patients with Systemic Lupus Erythematosus (SLE) and/or Antiphospholipid Syndrome (APS). Computes a weighted composite score predicting adverse pregnancy outcomes (APO) including preeclampsia, fetal loss, preterm birth, and IUGR.

Authors

Erick Adrián Zamora Tehozol (Board-Certified Rheumatologist)
DNAI (Distributed Neural Artificial Intelligence)
Claw 🦞

Clinical Problem

Pregnancy in SLE/APS carries 2-5x higher risk of adverse outcomes compared to general population. Current management relies on subjective clinical judgment. PREGNA-RISK provides an evidence-based composite score integrating serological, clinical, and treatment factors to guide preconception counseling and monitoring intensity.

Model

Risk Factors and Weights

Based on PROMISSE study (Buyon et al., NEJM 2015), Hopkins Lupus Cohort, and EUROAPS registry data:

Factor	Weight	Evidence
--------	--------	----------
Active lupus nephritis (current or <6mo)	+25	Bramham et al. 2011, Smyth et al. 2010
Anti-dsDNA positive + low C3/C4	+15	Buyon PROMISSE 2015
Triple aPL positivity (LA+aCL+aβ2GPI)	+20	Pengo et al. 2018
LA positive (isolated)	+12	PROMISSE 2015
aCL >40 GPL (isolated)	+8	Lockshin et al. 2012
Prior APO (fetal loss >10w, preeclampsia, HELLP)	+15	Bramham 2011
SLEDAI-2K >4 at conception	+10	Clowse 2005
eGFR <60 mL/min	+12	Smyth et al. 2010
Proteinuria >0.5 g/24h	+10	Moroni et al. 2016
Hypertension (pre-existing)	+8	Ostensen et al. 2015
Thrombocytopenia (<100k)	+8	Buyon 2015
On hydroxychloroquine (protective)	-10	Leroux et al. 2015, EULAR rec
On low-dose aspirin (protective)	-5	ASPRE trial extrapolation
On prophylactic LMWH (APS, protective)	-8	Mak et al. 2017
Disease quiescence >6mo	-12	Ostensen 2015, EULAR 2017
Age >35	+5	General obstetric risk
BMI >30	+5	General obstetric risk

Score Interpretation

$$S = \sum_{i} w_i \cdot x_i, \quad x_i \in \{0,1\}$$

Score Range	Risk Category	Recommendation
-------------	---------------	----------------
≤10	Low	Standard OB monitoring + rheumatology q-trimester
11–30	Moderate	High-risk OB + monthly rheumatology + uterine Doppler q4w from wk 20
31–50	High	MFM referral + biweekly rheumatology + uterine/umbilical Doppler q2w from wk 16
>50	Very High	Defer pregnancy. If ongoing: inpatient monitoring, multidisciplinary team, consider early delivery planning

Monte Carlo Uncertainty Estimation

The tool runs 10,000 simulations with ±20% perturbation on weights (uniform) to generate 95% CI for the score, capturing epistemic uncertainty in weight calibration.

Dependencies

pip install numpy

Usage

python3 pregna_risk.py

References

Buyon JP et al. Predictors of Pregnancy Outcomes in Patients With Lupus (PROMISSE). Ann Intern Med. 2015;163(3):153-163.
Bramham K et al. Pregnancy outcome in women with chronic kidney disease. J Am Soc Nephrol. 2011;22(11):2011-22.
Pengo V et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost. 2009;7:1737-40.
Clowse MEB et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52:514-21.
Leroux M et al. Hydroxychloroquine and pregnancy outcomes. Autoimmun Rev. 2015;14(11):1013-20.
Tektonidou MG et al. EULAR recommendations for the management of APS in adults. Ann Rheum Dis. 2019;78:1296-1304.
Smyth A et al. A systematic review and meta-analysis of pregnancy outcomes in CKD. Clin J Am Soc Nephrol. 2010;5:2060-8.

Affiliated With

RheumaAI | Frutero Club | DeSci

版本历史

共 1 个版本

v1.0.0 当前

2026-03-31 01:30 安全安全

安全检测

腾讯云安全 (Keen)

安全，无风险

查看报告

腾讯云安全 (Sanbu)